Ocean Biomedical Profitability Analysis
| OCEAW Stock | 0.04 0.01 14.25% |
Net Income | First Reported 2010-12-31 | Previous Quarter 508.9 K | Current Value 534.4 K | Quarterly Volatility 16.1 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.0059 | 0.0062 |
|
|
For Ocean Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ocean Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ocean Biomedical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ocean Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ocean Biomedical over time as well as its relative position and ranking within its peers.
Ocean |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ocean Biomedical EBITDA vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ocean Biomedical's current stock value. Our valuation model uses many indicators to compare Ocean Biomedical value to that of its competitors to determine the firm's financial worth. Ocean Biomedical is considered to be number one stock in number of shares shorted category among its peers. It is regarded third in ebitda category among its peers . At this time, Ocean Biomedical's EBITDA is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ocean Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Ocean EBITDA vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Ocean Biomedical |
| = | 33.05 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Ocean Biomedical |
| = | (957.74 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Ocean EBITDA Comparison
Ocean Biomedical is currently under evaluation in ebitda category among its peers.
Ocean Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ocean Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ocean Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Ocean Biomedical's change in net profit over the period of time. It can combine multiple indicators of Ocean Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -2.2 M | -2.3 M | |
| Net Loss | -862.6 K | -905.7 K | |
| Income Before Tax | -862.6 K | -905.7 K | |
| Net Loss | -862.6 K | -905.7 K | |
| Income Tax Expense | -1.4 M | -1.3 M | |
| Total Other Income Expense Net | 1.8 M | 1.8 M | |
| Net Interest Income | 1.4 M | 1.2 M | |
| Interest Income | 1.4 M | 1.2 M | |
| Net Income Per Share | 0.02 | 0.02 | |
| Income Quality | 0.70 | 0.74 | |
| Net Loss | (0.53) | (0.56) |
Ocean Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ocean Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ocean Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ocean Biomedical's important profitability drivers and their relationship over time.
Ocean Biomedical Profitability Trends
Ocean Biomedical profitability trend refers to the progression of profit or loss within a business. An upward trend means that Ocean Biomedical's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Ocean Biomedical's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.
Ocean Biomedical Profitability Drivers Correlations
One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Ocean Biomedical different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Ocean Biomedical in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Ocean Biomedical's future profitability.
Click cells to compare fundamentals
Use Ocean Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocean Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will appreciate offsetting losses from the drop in the long position's value.Ocean Biomedical Pair Trading
Ocean Biomedical Pair Trading Analysis
The ability to find closely correlated positions to Ocean Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocean Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocean Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocean Biomedical to buy it.
The correlation of Ocean Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocean Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocean Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocean Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ocean Biomedical position
In addition to having Ocean Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.